Vascular Complications in the Era of Transcatheter Treatment of Adult Structural Heart Disease: A Single-Center Early Experience

dc.contributor.authorWehbe, Mohammad Rachad
dc.contributor.authorSawaya, Fadi J.
dc.contributor.authorSabra, Mohammad
dc.contributor.authorHamadi, Caroline
dc.contributor.authorHoballah, Jamal Jawad
dc.contributor.authorHaddad, Fady F.
dc.contributor.departmentSurgery
dc.contributor.departmentInternal Medicine
dc.contributor.departmentDivision of Vascular Surgery
dc.contributor.departmentDivision of Cardiology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:13:23Z
dc.date.available2025-01-24T12:13:23Z
dc.date.issued2020
dc.description.abstractTranscatheter treatment is becoming the mainstay treatment for structural heart diseases (SHD) in prohibitive surgical risk patients. Recently with the encouraging results, it is being offered to regular risk patients. Peripheral vascular complications (VCs) are still inherent to these procedures due to the nature of this atherosclerotic high-risk group and the profile of the devices. This is a single-center early first year experience with such events occurring after initiating a SHD program treating severe aortic stenosis, aortic regurgitation, mitral valve prolapse and regurgitation, as well as paravalvular leaks. Out of 33 patients in this time period, 5 developed PV complications which are detailed in this article with their associated risk factors and management. These include access-related complications, closure device issues, arterial rupture post device embolization, and vessel dissection. Vascular complications of those procedures take special interest since they are associated with a worse long-term prognosis. Thus, prevention with proper planning remains of essence along with multidisciplinary management. © The Author(s) 2020.
dc.identifier.doihttps://doi.org/10.1177/1538574420934620
dc.identifier.eid2-s2.0-85086660166
dc.identifier.pmid32552506
dc.identifier.urihttp://hdl.handle.net/10938/33028
dc.language.isoen
dc.publisherSAGE Publications Inc.
dc.relation.ispartofVascular and Endovascular Surgery
dc.sourceScopus
dc.subjectHeart disease
dc.subjectTavi
dc.subjectTranscatheter
dc.subjectVascular
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectCardiac catheterization
dc.subjectCatheterization, peripheral
dc.subjectFemale
dc.subjectHeart diseases
dc.subjectHumans
dc.subjectLebanon
dc.subjectMale
dc.subjectMiddle aged
dc.subjectRetrospective studies
dc.subjectRisk factors
dc.subjectTreatment outcome
dc.subjectVascular diseases
dc.subjectAdult
dc.subjectAortic bifurcation
dc.subjectAortic regurgitation
dc.subjectAortic stenosis
dc.subjectAortic valve repair
dc.subjectArtery dissection
dc.subjectArtery perforation
dc.subjectArtery rupture
dc.subjectArticle
dc.subjectBalloon occlusion
dc.subjectCase report
dc.subjectClinical article
dc.subjectComputed tomographic angiography
dc.subjectCoronary artery disease
dc.subjectDeep femoral artery
dc.subjectDevice migration
dc.subjectDyslipidemia
dc.subjectEndarterectomy
dc.subjectFalse aneurysm
dc.subjectHuman
dc.subjectHypertension
dc.subjectHypotension
dc.subjectLaparotomy
dc.subjectMitral valve regurgitation
dc.subjectMitral valve repair
dc.subjectParavalvular leak
dc.subjectPatch angioplasty
dc.subjectPostoperative complication
dc.subjectProspective study
dc.subjectRetrospective study
dc.subjectStructural heart disease
dc.subjectTranscatheter aortic valve implantation
dc.subjectVery elderly
dc.subjectAdverse event
dc.subjectCatheterization
dc.subjectDevices
dc.subjectDiagnostic imaging
dc.subjectHeart catheterization
dc.subjectRisk factor
dc.subjectVascular disease
dc.titleVascular Complications in the Era of Transcatheter Treatment of Adult Structural Heart Disease: A Single-Center Early Experience
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2020-3123.pdf
Size:
386.54 KB
Format:
Adobe Portable Document Format